Evaluation of the effectiveness and factors associated with the treatment outcomes of high‑flow nasal cannula and bilevel positive airway pressure in patients with chronic obstructive pulmonary disease with moderate respiratory failure

Tran,Tung Xuan; Phan,Phuong Thu; Do,Son Ngoc

doi:10.3892/wasj.2025.339

Evaluation of the effectiveness and factors associated with the treatment outcomes of high‑flow nasal cannula and bilevel positive airway pressure in patients with chronic obstructive pulmonary disease with moderate respiratory failure

Authors:
- Tung Xuan Tran
- Phuong Thu Phan
- Son Ngoc Do
View Affiliations

Affiliations: Department of Internal Medicine, Hanoi Medical University, Hanoi 100000, Vietnam, Intensive Care Center, Bach Mai Hospital, Hanoi 100000, Vietnam
Published online on: April 1, 2025 https://doi.org/10.3892/wasj.2025.339
Article Number: 51
Copyright : © Tran et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study compared the effectiveness of the non‑invasive respiratory support therapies, bilevel positive airway pressure (BiPAP) and high‑flow nasal cannula (HFNC) in 176 patients with chronic obstructive pulmonary disease (COPD) with hypercapnia, divided into two treatment groups. The results indicated that the BiPAP group achieved a significant reduction in the mean partial pressure of carbon dioxide in arterial blood, decreasing from 54.14±10.40 to 47.06±5.99 mmHg, compared with a reduction from 55.97±10.50 to 50.31±7.32 mmHg in the HFNC group. Oxygen saturation levels were more stable in the BiPAP group, particularly prior to the intervention and at 2 h. Additionally, BiPAP significantly reduced breathing effort, with respiratory rates decreasing from 27.02±1.36 to 22.09±10.23 breaths/min, compared with a reduction from 26.07±1.99 to 22.36±1.83 breaths/min in the HFNC group. HFNC was associated with greater patient comfort, with 85% of the patients reporting ease of use, compared with 68% in the BiPAP group. In conclusion, BiPAP remains the preferred treatment for acute COPD exacerbations with hypercapnia, while HFNC serves as an adjunct option for milder cases or long‑term support.

View Figures

View References

1	Khan KS, Jawaid S, Memon UA, Perera T, Khan U, Farwa UE, Jindal U, Afzal MS, Razzaq W, Abdin ZU and Khawaja UA: Management of chronic obstructive pulmonary disease (COPD) exacerbations in hospitalized patients from admission to discharge: A comprehensive review of therapeutic interventions. Cureus. 15(e43694)2023.PubMed/NCBI View Article : Google Scholar
2	Cortegiani A, Longhini F, Madotto F, Groff P, Scala R, Crimi C, Carlucci A, Bruni A, Garofalo E, Raineri SM, et al: High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care. 24(692)2020.PubMed/NCBI View Article : Google Scholar
3	Storgaard LH, Hockey HU, Laursen BS and Weinreich UM: Long-term effects of oxygen-enriched high-flow nasal cannula on COPD patients with chronic hypoxemi respiratory failure. Int J Chron Obstruct Pulmon Dis. 13:1195–1205. 2018.PubMed/NCBI View Article : Google Scholar
4	Petkar S, Wanjari D and Priya V: A comprehensive review on high-flow nasal cannula oxygen therapy in critical care: evidence-based insights and future directions. Cureus. 16(e66264)2024.PubMed/NCBI View Article : Google Scholar
5	Cortegiani A, Longhini F, Carlucci A, Scala R, Groff P, Bruni A, Garofalo E, Taliani MR, Maccari U, Vetrugno L, et al: High-flow nasal therapy versus noninvasive ventilation in COPD patients with mild-to-moderate hypercapnic acute respiratory failure: study protocol for a noninferiority randomized clinical trial. Trials. 20(450)2019.PubMed/NCBI View Article : Google Scholar
6	Frat JP, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, Prat G, Boulain T, Morawiec E, Cottereau A, et al: High-Flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 372:2185–2196. 2015.PubMed/NCBI View Article : Google Scholar
7	Mukherjee D and Mukherjee R: High-flow nasal cannula oxygen therapy in the management of respiratory failure: A review. Cureus. 15(e50738)2023.PubMed/NCBI View Article : Google Scholar
8	Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report, 2024. https://goldcopd.org/2024-gold-report/.
9	Bräunlich J, Köhler M and Wirtz H: Nasal highflow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis. 11:1077–1085. 2016.PubMed/NCBI View Article : Google Scholar
10	Di Mussi R, Spadaro S, Stripoli T, Volta CA, Trerotoli P, Pierucci P, Staffieri F, Bruno F, Camporota L and Grasso S: High-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease. Crit Care. 22(180)2018.PubMed/NCBI View Article : Google Scholar
11	Rittayamai N, Phuangchoei P, Tscheikuna J, Praphruetkit N and Brochard L: Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: A preliminary study. Ann Intensive Care. 9(122)2019.PubMed/NCBI View Article : Google Scholar
12	Storgaard LH, Hockey HU and Weinreich UM: Development in PaCO₂ over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial. BMJ Open Respir Res. 7(e000712)2020.PubMed/NCBI View Article : Google Scholar
13	Roca O, Hernández G, Díaz-Lobato S, Carratalá JM, Gutiérrez RM and Masclans JR: Spanish Multidisciplinary Group of High Flow Supportive Therapy in Adults (HiSpaFlow). Current evidence for the effectiveness of heated and humidified high flow nasal cannula supportive therapy in adult patients with respiratory failure. Crit Care. 20(109)2016.PubMed/NCBI View Article : Google Scholar
14	Pisani L, Astuto M, Prediletto I and Longhini F: High flow through nasal cannula in exacerbated COPD patients: A systematic review. Pulmonology. 25:348–354. 2019.PubMed/NCBI View Article : Google Scholar
15	Zhang L, Wang Y, Ye Y, Gao J, Zhu F and Min L: Comparison of high-flow nasal cannula with conventional oxygen therapy in patients with hypercapnic chronic obstructive pulmonary disease: A systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 18:895–906. 2023.PubMed/NCBI View Article : Google Scholar
16	Kim ES, Lee H, Kim SJ, Park J, Lee YJ, Park JS, Yoon HI, Lee JH, Lee CT and Cho YJ: Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis. 10:882–888. 2018.PubMed/NCBI View Article : Google Scholar
17	Sun J, Li Y, Ling B, Zhu Q, Hu Y, Tan D, Geng P and Xu J: High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: An observational cohort study. Int J Chron Obstruct Pulmon Dis. 14:1229–1237. 2019.PubMed/NCBI View Article : Google Scholar